MRI-based Risk Scoring System to Predict Early Recurrence after Resection of Solitary Hepatocellular Carcinoma 5 cm or Smaller

The MRI-based Early Recurrence Individualized Score (known as MERIS) demonstrated superior performance in predicting early recurrence risk after resection of solitary hepatocellular carcinoma 5 cm or smaller compared with pathologic analysis–based and existing prognostic systems.